{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:52:51Z","timestamp":1777423971569,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,25]],"date-time":"2011-09-25T00:00:00Z","timestamp":1316908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00210-011-0691-1","type":"journal-article","created":{"date-parts":[[2011,9,24]],"date-time":"2011-09-24T16:25:10Z","timestamp":1316881510000},"page":"51-56","source":"Crossref","is-referenced-by-count":7,"title":["Rilmenidine improves hepatic steatosis through p38-dependent pathway to higher the expression of farnesoid X receptor"],"prefix":"10.1007","volume":"385","author":[{"given":"Po-Sheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Tsung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Hui","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Ta","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Wen","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Hua","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juei-Tang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,25]]},"reference":[{"key":"691_CR1","doi-asserted-by":"crossref","first-page":"84S","DOI":"10.1016\/S0895-7061(00)00223-5","volume":"13","author":"P Bousquet","year":"2000","unstructured":"Bousquet P (2000) Identification and characterization of I1 imidazoline receptors: their role in blood pressure regulation. Am J Hypertens 13:84S\u201388S","journal-title":"Am J Hypertens"},{"key":"691_CR2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1194\/jlr.M001602","volume":"51","author":"S Cipriani","year":"2010","unstructured":"Cipriani S, Mencarelli A, Palladino G, Fiorucci S (2010) FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa\/fa) obese rats. J Lipid Res 51:771\u2013784","journal-title":"J Lipid Res"},{"key":"691_CR3","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.0000178994.21828.a7","volume":"25","author":"T Claudel","year":"2005","unstructured":"Claudel T, Staels B, Kuipers F (2005) The farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol 25:2020\u20132030","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"691_CR4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1471-4159.2001.00632.x","volume":"79","author":"L Edwards","year":"2001","unstructured":"Edwards L, Fishman D, Horowitz P, Bourbon N, Kester M, Ernsberger P (2001) The I1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinases C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK). J Neurochem 79:931\u2013940","journal-title":"J Neurochem"},{"key":"691_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0022-2275(20)30180-2","volume":"43","author":"PA Edwards","year":"2002","unstructured":"Edwards PA, Kast HR, Anisfeld AM (2002) BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res 43:2\u201312","journal-title":"J Lipid Res"},{"key":"691_CR6","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/j.1476-5381.2009.00444.x","volume":"158","author":"MM El-Mas","year":"2009","unstructured":"El-Mas MM, El-Gowelli HM, Ghazal AR, Harraz OF, Mohy El-Din MM (2009) Facilitation of central imidazoline I(1)-site\/extracellular signal-regulated kinase\/p38 mitogen-activated protein kinase signalling mediates the hypotensive effect of ethanol in rats with acute renal failure. Br J Pharmacol 158:1629\u20131640","journal-title":"Br J Pharmacol"},{"key":"691_CR7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.1995.tb32388.x","volume":"763","author":"P Ernsberger","year":"1995","unstructured":"Ernsberger P, Graves ME, Graff LM, Zakieh N, Nguyen P, Collins LA, Westbrooks KL, Johnson GG (1995) I1-imidazoline receptors. Definition, characterization, distribution, and transmembrane signaling. Ann N Y Acad Sci 763:22\u201342","journal-title":"Ann N Y Acad Sci"},{"key":"691_CR8","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00004872-199715011-00002","volume":"15","author":"P Ernsberger","year":"1997","unstructured":"Ernsberger P, Friedman JE, Koletsky RJ (1997) The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J Hypertens Suppl 15:S9\u201323","journal-title":"J Hypertens Suppl"},{"key":"691_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1467-789X.2004.00126.x","volume":"5","author":"D Festi","year":"2004","unstructured":"Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G (2004) Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev 5:27\u201342","journal-title":"Obes Rev"},{"key":"691_CR10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","volume":"81","author":"BM Forman","year":"1995","unstructured":"Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, Evans RM, Weinberger C (1995) Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81:687\u2013693","journal-title":"Cell"},{"key":"691_CR11","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1210\/me.15.10.1720","volume":"15","author":"HR Kast","year":"2001","unstructured":"Kast HR, Nguyen CM, Sinal CJ, Jones SA, Laffitte BA, Reue K, Gonzalez FJ, Willson TM, Edwards PA (2001) Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. Mol Endocrinol 15:1720\u20131728","journal-title":"Mol Endocrinol"},{"key":"691_CR12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10620-009-1081-0","volume":"55","author":"JR Lewis","year":"2010","unstructured":"Lewis JR, Mohanty SR (2010) Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 55:560\u2013578","journal-title":"Dig Dis Sci"},{"key":"691_CR13","doi-asserted-by":"crossref","first-page":"37735","DOI":"10.1074\/jbc.R100035200","volume":"276","author":"TT Lu","year":"2001","unstructured":"Lu TT, Repa JJ, Mangelsdorf DJ (2001) Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J Biol Chem 276:37735\u201337738","journal-title":"J Biol Chem"},{"key":"691_CR14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neulet.2010.03.024","volume":"474","author":"TN Lui","year":"2010","unstructured":"Lui TN, Tsao CW, Huang SY, Chang CH, Cheng JT (2010) Activation of imidazoline I2B receptors is linked with AMP kinase pathway to increase glucose uptake in cultured C2C12 cells. Neurosci Lett 474:144\u2013147","journal-title":"Neurosci Lett"},{"key":"691_CR15","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1021\/jm0002127","volume":"43","author":"PR Maloney","year":"2000","unstructured":"Maloney PR, Parks DJ, Haffner CD, Fivush AM, Chandra G, Plunket KD, Creech KL, Moore LB, Wilson JG, Lewis MC, Jones SA, Willson TM (2000) Identification of a chemical tool for the orphan nuclear receptor FXR. J Med Chem 43:2971\u20132974","journal-title":"J Med Chem"},{"key":"691_CR16","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","volume":"37","author":"BA Neuschwander-Tetri","year":"2003","unstructured":"Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37:1202\u20131219","journal-title":"Hepatology"},{"key":"691_CR17","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-0031-1275325","volume":"43","author":"CS Niu","year":"2011","unstructured":"Niu CS, Wu HT, Cheng KC, Lin KC, Chen CT, Cheng JT (2011) A novel mechanism for decreasing plasma lipid level from imidazoline I-1 receptor activation in high fat diet-fed mice. Horm Metab Res 43:458\u2013463","journal-title":"Horm Metab Res"},{"key":"691_CR18","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1046\/j.1471-4159.1998.71041429.x","volume":"71","author":"MA Ozog","year":"1998","unstructured":"Ozog MA, Wilson JX, Dixon SJ, Cechetto DF (1998) Rilmenidine elevates cytosolic free calcium concentration in suspended cerebral astrocytes. J Neurochem 71:1429\u20131435","journal-title":"J Neurochem"},{"key":"691_CR19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.bjp.0704153","volume":"133","author":"W Raasch","year":"2001","unstructured":"Raasch W, Schafer U, Chun J, Dominiak P (2001) Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Br J Pharmacol 133:755\u2013780","journal-title":"Br J Pharmacol"},{"key":"691_CR20","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/nm1102-1243","volume":"8","author":"JJ Repa","year":"2002","unstructured":"Repa JJ, Mangelsdorf DJ (2002) The liver X receptor gene team: potential new players in atherosclerosis. Nat Med 8:1243\u20131248","journal-title":"Nat Med"},{"key":"691_CR21","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0026-895X(25)08781-4","volume":"49","author":"D Separovic","year":"1996","unstructured":"Separovic D, Kester M, Ernsberger P (1996) Coupling of I1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells. Mol Pharmacol 49:668\u2013675","journal-title":"Mol Pharmacol"},{"key":"691_CR22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0006-8993(96)01372-8","volume":"749","author":"D Separovic","year":"1997","unstructured":"Separovic D, Kester M, Haxhiu MA, Ernsberger P (1997) Activation of phosphatidylcholine-selective phospholipase C by I1-imidazoline receptors in PC12 cells and rostral ventrolateral medulla. Brain Res 749:335\u2013339","journal-title":"Brain Res"},{"key":"691_CR23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","volume":"102","author":"CJ Sinal","year":"2000","unstructured":"Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ (2000) Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis. Cell 102:731\u2013744","journal-title":"Cell"},{"key":"691_CR24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.23314","volume":"51","author":"C Soderberg","year":"2010","unstructured":"Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, Hultcrantz R (2010) Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 51:595\u2013602","journal-title":"Hepatology"},{"key":"691_CR25","doi-asserted-by":"crossref","unstructured":"Sun C, Wang L, Yan J, Liu S (2011) Calcium ameliorates obesity induced by high-fat diet and its potential correlation with p38 MAPK pathway. Mol Biol Rep. doi: 10.1007\/s11033-011-0916-x","DOI":"10.1007\/s11033-011-0916-x"},{"key":"691_CR26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCRESAHA.107.160457","volume":"101","author":"LS Szczepaniak","year":"2007","unstructured":"Szczepaniak LS, Victor RG, Orci L, Unger RH (2007) Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res 101:759\u2013767","journal-title":"Circ Res"},{"key":"691_CR27","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.2337\/diabetes.54.12.3541","volume":"54","author":"G Targher","year":"2005","unstructured":"Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, Zenari L, Falezza G (2005) Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54:3541\u20133546","journal-title":"Diabetes"},{"key":"691_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","volume":"5","author":"DG Tiniakos","year":"2010","unstructured":"Tiniakos DG, Vos MB, Brunt EM (2010) Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 5:145\u2013171","journal-title":"Annu Rev Pathol"},{"key":"691_CR29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00210-005-0024-3","volume":"372","author":"RA Velliquette","year":"2006","unstructured":"Velliquette RA, Kossover R, Previs SF, Ernsberger P (2006) Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X. Naunyn Schmiedebergs Arch Pharmacol 372:300\u2013312","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"691_CR30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0005-2760(88)90082-3","volume":"961","author":"SR Wang","year":"1988","unstructured":"Wang SR, Pessah M, Infante J, Catala D, Salvat C, Infante R (1988) Lipid and lipoprotein metabolism in Hep G2 cells. Biochim Biophys Acta 961:351\u2013363","journal-title":"Biochim Biophys Acta"},{"key":"691_CR31","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","volume":"113","author":"M Watanabe","year":"2004","unstructured":"Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, Moore DD, Auwerx J (2004) Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 113:1408\u20131418","journal-title":"J Clin Invest"},{"key":"691_CR32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hep.21768","volume":"46","author":"A Wieckowska","year":"2007","unstructured":"Wieckowska A, McCullough AJ, Feldstein AE (2007) Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 46:582\u2013589","journal-title":"Hepatology"},{"key":"691_CR33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00210-011-0598-x","volume":"383","author":"DM Wu","year":"2011","unstructured":"Wu DM, Zhao D, Li DZ, Xu DY, Chu WF, Wang XF (2011) Maslinic acid induces apoptosis in salivary gland adenoid cystic carcinoma cells by Ca2+-evoked p38 signaling pathway. Naunyn Schmiedebergs Arch Pharmacol 383:321\u2013330","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"691_CR34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1074\/jbc.M209505200","volume":"278","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Kast-Woelbern HR, Edwards PA (2003) Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. J Biol Chem 278:104\u2013110","journal-title":"J Biol Chem"},{"key":"691_CR35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1101\/gad.1138104","volume":"18","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, Edwards PA (2004) Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev 18:157\u2013169","journal-title":"Genes Dev"},{"key":"691_CR36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cmet.2010.03.012","volume":"11","author":"D Zhang","year":"2010","unstructured":"Zhang D, Christianson J, Liu ZX, Tian L, Choi CS, Neschen S, Dong J, Wood PA, Shulman GI (2010) Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency. Cell Metab 11:402\u2013411","journal-title":"Cell Metab"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-011-0691-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-011-0691-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-011-0691-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:09:09Z","timestamp":1741738149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-011-0691-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,25]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["691"],"URL":"https:\/\/doi.org\/10.1007\/s00210-011-0691-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,25]]}}}